From size to function: moving beyond body mass index to frailty and central adiposity phenotypes
By
Ryan Ruiyang Ling
Ashwin Subramaniam
June 30, 2026
Clinical Scorecard: Beyond Body Mass Index: Exploring Frailty and Central Adiposity Phenotypes in Relation to Function
At a Glance
Category Detail
Condition Critical Illness Key Mechanisms Frailty and central adiposity impact functional reserve and outcomes. Target Population Patients admitted to the ICU. Care Setting Intensive Care Unit (ICU)
Key Highlights
BMI has limitations in individual prognostication despite its widespread use. Frailty, assessed by the Clinical Frailty Scale (CFS), is linked to poorer outcomes. Combining BMI and frailty may enhance risk stratification in critical illness. Sarcopenic obesity is a significant but under-recognized high-risk group. A multidimensional approach to risk assessment is needed for better prognostic precision. Guideline-Based Recommendations
Diagnosis
Utilize BMI and CFS for assessing patient risk in ICU. Management
Focus on nutritional and metabolic management, including early mobilization. Monitoring & Follow-up
Regularly assess frailty and body composition metrics in ICU patients. Risks
Patients with sarcopenic obesity may have higher disease burden and poorer outcomes. Patient & Prescribing Data
ICU patients with varying BMI and frailty levels.
Nutritional support and functional assessments are critical for management.
Clinical Best Practices
Incorporate frailty assessments alongside BMI measurements. Develop composite indices integrating BMI, frailty, and clinical variables. Enhance institutional protocols for measuring functional reserve. Related Resources & Content
